NI
EGRX

Numeric Investors’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Numeric Investors’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-3,300
Closed -$267K – 1183
2015
Q2 		$267K Sell
3,300
-55,731
-94% -$3.63M ﹤0.01% 792
2015
Q1 		$2.47M Buy
59,031
+26,161
+80% +$742K 0.03% 334
2014
Q4 		$509K Sell
32,870
-24,000
-42% -$306K 0.01% 606
2014
Q3 		$719K Buy
+56,870
New +$705K 0.01% 495

Other funds holding EGRX

PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
GE
General Electric Evendale, Ohio $369M AUM 19.65% 1-Year Est. Return

Numeric Investors's EGRX Position: Q3 2015 in Review

Numeric Investors sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q3 2015, closing a stake of 3,300 shares — an estimated $267K sold.

Numeric Investors first reported a position in EGRX in Q3 2014 and held it in 4 quarters. The position peaked at $2.47M in Q1 2015. 119 funds tracked by Wall St. Rank hold EGRX as of Q3 2015.

  • Numeric Investors reported no remaining Eagle Pharmaceuticals, Inc. position as of Q3 2015 after selling out during the quarter.
  • Numeric Investors sold 3,300 Eagle Pharmaceuticals, Inc. shares in Q3 2015, an estimated $267K.
  • Numeric Investors first reported a position in Eagle Pharmaceuticals, Inc. in Q3 2014 and held it in 4 quarters.
  • Numeric Investors's Eagle Pharmaceuticals, Inc. position peaked at $2.47M in Q1 2015.
  • 119 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q3 2015.

Based on Numeric Investors's 13F filing for Q3 2015, filed 12 Nov 2015.